Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Cytochrome P450 family 4 subfamily F member 9 pseudogene (CYP4F9P, also known as LOC124900424) is classified as a **pseudogene** in the human genome and is part of the cytochrome P450 superfamily, specifically within the CYP4F subfamily[1][2][3][4]. Unlike functional members of this family, which encode enzymes involved in drug metabolism and fatty acid oxidation, CYP4F9P contains mutations that prevent it from producing a functional protein[2][3]. It is considered non-functional and does not contribute to biological pathways or serve as a therapeutic target, and no drugs are known to act on this pseudogene[2][3][4]. The presence of CYP4F9P is of evolutionary interest but has no established role in human physiology or disease.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Cytochrome P450 family 4 subfamily F member 9 pseudogene (CYP4F9P).